Lily Wang, PhD

Dr. Li Lily Wang is currently Associate Staff of Department of Translational Hematology and Oncology Research at Cleveland Clinic, and Associate Professor of Department of Molecular Medicine, at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University (CCLCM).   Research in Dr. Wang’s laboratory focuses on identifying the novel immune regulatory mechanisms in the context of antitumor immunity. Previous studies in Dr. Wang’s team have unveiled the key role of an immune checkpoint protein VISTA as a promising target for cancer immunotherapy. Currently, Dr. Wang’s team is working with multi-disciplinary collaborators to dissect the potential VISTA-related mechanisms underlying the therapeutic resistance to current immunotherapies.